Perrigo's Turnaround Tools: 'National Brand,' Novel NRTs, CBD And Natural Products, Sponsoring OTC Switches
Following investor day conference, market analysts gave Perrigo points for an ambitious three-year plan while also noting the degree of difficulty it faces in succeeding. Other changes planned to stem slump sales and earnings slump include potentially getting into CBD supplement space and getting back into VMS manufacturing after leaving the sector in one of several moves since 2015 intended to help drive net income and improve its margin.
You may also be interested in...
HRA brings needed expertise in OTC switches to Perrigo, which regularly is first to launch generic equivalents for brand switches but its name hasn’t been linked to submitting proposals for making additional drug ingredients available OTC.
Perrigo has struck a deal with Advent International to offload its "sub scale" and margin-dilutive OTC businesses in Mexico and Brazil.
“Formal partnership” connects Michigan State's clinical and research expertise with Perrigo's product innovation, manufacturing scale and retail distribution network, Despite breadth and depth of Perrigo’s product lineup, it expects another $1b annually could come from segments where it has no or little market share.